As we all know, increased serum IL6 levels uniformly appear to correlate with advanced stages and poor survival independent of the cancer type.49,50 However, there is scarcely evidence that IL6 level is associated with the occurrence and development of brain metastases in NSCLC patients. Here, IL6 is linked to cancer.